ASX:HLS

Healius Stock Forecast, Price & News

Add
Compare
Today's Range N/A
50-Day Range N/A
52-Week Range N/A
Volume2.33 million shs
Average VolumeN/A
Market CapitalizationN/A
P/E RatioN/A
Dividend Yield2.73%
BetaN/A

Receive HLS News and Ratings via Email

Sign-up to receive the latest news and ratings for Healius and its competitors with MarketBeat's FREE daily newsletter.


About Healius

Healius Limited provides facilities and support services to independent general practitioners, radiologists, and other healthcare professionals in Australia. The company operates through three segments: Pathology, Imaging, and Day Hospitals. It offers diagnostic imaging services, including X-ray, ultrasound, computerized tomography, mammography, magnetic resonance imaging, nuclear medicine, positron emission tomography, and interventional radiology; and private medical laboratory and pathology services. The company also provides cataract surgery, colonoscopy, gastroscopy, plastic and cosmetic surgery, skin, cancer removal, IVF egg collection, and gynaecological surgery services. It operates 2,234 pathology sites; 15 day hospital sites; and 146 imaging sites. The company was formerly known as Primary Health Care Limited and changed its name to Healius Limited in December 2018. Healius Limited was incorporated in 1994 and is based in St Leonards, Australia.

Headlines

See More Headlines

Industry, Sector and Symbol

Sales & Book Value

Profitability

Debt

Price-To-Earnings

Miscellaneous


MarketRank

Overall MarketRank

1.10 out of 5 stars

Analyst Opinion: 0.0Community Rank: 4.7Dividend Strength: 0.8Insider Behavior: 0.0Valuation: 0.0 5 -4 -3 -2 -1 -
speech bubbles
speech bubbles











Healius (ASX:HLS) Frequently Asked Questions

What stocks does MarketBeat like better than Healius?

Wall Street analysts have given Healius a "N/A" rating, but there may be better buying opportunities in the stock market. Some of MarketBeat's past winning trading ideas have resulted in 5-15% weekly gains. MarketBeat just released five new stock ideas, but Healius wasn't one of them. MarketBeat thinks these five companies may be even better buys.
View MarketBeat's top stock picks here.

When is Healius' next earnings date?

Healius is scheduled to release its next quarterly earnings announcement on Monday, August 30th 2021.
View our earnings forecast for Healius
.

How were Healius' earnings last quarter?

Healius Limited (ASX:HLS) issued its earnings results on Friday, February, 15th. The company reported $0.04 earnings per share (EPS) for the quarter, missing the consensus estimate of $0.09 by $0.06.
View Healius' earnings history
.

How often does Healius pay dividends? What is the dividend yield for Healius?

Healius announced a Interim dividend on Thursday, February 25th. Shareholders of record on Wednesday, April 14th will be paid a dividend of 0.065 per share on Wednesday, April 14th. This represents a yield of 1.57%. The ex-dividend date is Wednesday, March 24th. This is a positive change from Healius's previous Interim dividend of A$0.03.
View Healius' dividend history
.

Is Healius a good dividend stock?

Healius pays an annual dividend of A$0.13 per share and currently has a dividend yield of 2.73%.
View Healius' dividend history.

Who are Healius' key executives?

Healius' management team includes the following people:
  • Dr. Malcolm W. Parmenter B.S., M.A.I.C.D., M.S., MD, CEO & Director (Age 66, Pay $1.64M)
  • Ms. Maxine Jacquet, Chief Financial Officer
  • Mr. Dean Lewsam, Chief Exec. of Imaging
  • Mr. John McKechnie, Chief Exec. of the Pathology Division
  • Mr. Peter Wilson, Group Exec. of People & Shared Services (Age 61)
  • Mr. Ben Korst, CEO of Montserrat Day Hospitals
  • Mr. Charles Tilley B.Sc., FCIS, L.L.B., B.Sc. (Hons), LLB (Hons), Company Sec.
  • Ms. Alison Stephenson, Additional Company Sec.
  • Ms. Janet Payne, Group Exec. of Corp. Affairs
  • Dr. John Houston, Advisor

Who are some of Healius' key competitors?

What other stocks do shareholders of Healius own?

What is Healius' stock symbol?

Healius trades on the ASX under the ticker symbol "HLS."

How much money does Healius make?

Healius has a market capitalization of $0.00 and generates $1.73 billion in revenue each year.

How many employees does Healius have?

Healius employs 12,500 workers across the globe.

What is Healius' official website?

The official website for Healius is www.primaryhealthcare.com.au.

How can I contact Healius?

The company can be reached via phone at 61 2 9432 9400.


This page was last updated on 8/2/2021 by MarketBeat.com Staff
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

MarketBeat is accredited by the Better Business Bureau

© American Consumer News, LLC dba MarketBeat® 2010-2021. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information

© 2021 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research.